➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Colorcon
McKesson
Medtronic
Johnson and Johnson

Last Updated: August 4, 2021

DrugPatentWatch Database Preview

Patent: 5,578,324

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 5,578,324
Title: Peptide proteinaceous drug nasal powder composition
Abstract:A peptide proteinaceous drug nasal powder composition containing (i) an absorption accelerant comprised of a compound, or its salt, having in its molecule a group expressed by the formula (I): ##STR1## wherein, ##STR2## indicates a cyclohexane ring or a benzene ring which may be substituted at least one of its 3-position, 4-position, and 5-position and n is an integer of 1 to 3 and (ii) a therapeutically effective amount of a peptide proteinaceous drug.
Inventor(s): Dohi; Masahiko (Hino, JP), Nishibe; Yoshihisa (Fuchu, JP), Makino; Yuji (Hino, JP), Suzuki; Yoshiki (Hino, JP)
Assignee: Teijin Limited (Osaka, JP)
Application Number:08/407,000
Patent Claims:see list of patent claims

Details for Patent 5,578,324

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ⤷  Free Forever Trial Teijin Limited (Osaka, JP) 2013-11-26 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ⤷  Free Forever Trial Teijin Limited (Osaka, JP) 2013-11-26 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ⤷  Free Forever Trial Teijin Limited (Osaka, JP) 2013-11-26 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23 ⤷  Free Forever Trial Teijin Limited (Osaka, JP) 2013-11-26 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 5,578,324

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 9503818 ⤷  Free Forever Trial
South Korea 100327563 ⤷  Free Forever Trial
South Korea 950703352 ⤷  Free Forever Trial
Japan 2974412 ⤷  Free Forever Trial
Spain 2171459 ⤷  Free Forever Trial
European Patent Office 0667163 ⤷  Free Forever Trial
Germany 69430295 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Moodys
Express Scripts
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.